Ironwood Pharma (IRWD) Misses Q1 EPS by 4c

Ironwood Pharma (NASDAQ: IRWD) reported Q1 EPS of ($0.27), $0.04 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $69.16 million versus the consensus estimate of $78.87 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Ridgepost Capital acquires Stellus Capital Management for $4B AUM
• Worried the AI trade has gone too far? Evercore likes these 4 stocks